Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

PHYLOGICA AND ROCHE EXTEND COLLABORATION TO EVALUATE POTENTIAL FOR PHYLOMER DELIVERY TO BRAIN (ASX:PYC)

PERTH, AUSTRALIA: May 23, 2011 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today an extension of its collaboration with the Swiss Ph...read more

PHYLOGICA AND PEPSCAN ENTER COLLABORATION TO OPTIMISE THERAPEUTIC PHYLOMER® DRUG CANDIDATES (ASX:PYC)

PERTH, AUSTRALIA, and LELYSTAD, THE NETHERLANDS: May 10, 2011 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, and Pepscan Therapeutics, a Dutch ...read more

PHYLOGICA ANNOUNCES NEW PATENT FOR DRUG SCREENING TECHNOLOGY (ASX:PYC)

Claims granted for rapid s screening against targets inside cells Perth, Australia: April 11, 22011 – Australian drug discovery company Phylogica Ltd (ASX:PYC) today announced that a ke...read more

Phylogica Limited Share Placement raises $5.2 million (ASX:PYC)

Phylogica Limited (Phylogica) today announced that it has successfully completed a share placement to international institutional and sophisticated investors, led by Ascent Biomedical Holdings LP, ...read more

HARNESSING NATURAL DIVERSITY FOR DRUG DISCOVERY (ASX:PYC)

Executive Chairman Doug Wilson continues to use this informal update as a forum to put recent announcements in context for shareholders in a consolidated newsletter. Please download PDF below.

PHYLOGICA FORMS TARGET DISCOVERY SPIN-OFF WITH UNIVERSITY OF CAMBRIDGE (ASX:PYC)

..Unique platform for discovery of new disease-associated targets ..World-renowned scientists to spearhead target discovery program ..‘Phenomica’ to license IP from both Cambrid...read more

PHYLOGICA & ISOGENICA: TECHNOLOGY COLLABORATION (ASX:PYC)

Strategic alliance fast tracking screening of drug discovery targets. Perth, Australia, February 23, 2011: – Australian drug discovery company Phylogica Ltd (ASX:PYC), ( XETRA PH7) and U...read more

PHYLOGICA: NEW POTENTIAL FOR TREATING BRAIN INJURY (ASX:PYC)

Novel compound protects neural tissue, reduces inflammation Company seeking to out-license novel compound PERTH, AUSTRALIA, 21 February 2011 – Australian drug di...read more

Phylogica Named as One of Bioshares ‘Top 10 Picks’ for 2011 (ASX:PYC)

PERTH, AUSTRALIA, January 25, 2011 - Phylogica Ltd (ASX:PYC), (XETRA:PH7), a leading Australian drug discovery company, announced today that it has been named as one of the annual Bioshares ‘...read more

Phylogica Receives Prestigious Frost & Sullivan Innovation Award (ASX:PYC)

PERTH, AUSTRALIA, January 24, 2011 - Phylogica Ltd (ASX:PYC), (XETRA:PH7), a leading Australian drug discovery company, announced today that it has received the 2011 Asia Pacific Frost & Sulliv...read more

Phylogica Signs Collaboration and Licensing Deal with Pfizer (ASX:PYC)

PERTH, AUSTRALIA - Phylogica Ltd (ASX:PYC), a public Australian drug discovery company, announced today that it has entered into a collaboration and licensing agreement with Pfizer to discover nove...read more

Viewing: 106 - 120 of 116 Previous | Next